TETRALOGIC PHARMACEUTICALS CORP Comprehensive Income
TETRALOGIC PHARMACEUTICALS CORP reported Comprehensive Income of -$8.65 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-09-30 was -$8.65M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-06-30 was -$6.75M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-03-31 was -$11.05M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2015-12-31 was -$14.30M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$49.72M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$36.04M.
- TETRALOGIC PHARMACEUTICALS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$19.95M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 126 month |
|---|---|---|---|---|---|
| 2016-09-30 | -$8.65M 10-Q · filed 2016-11-03 | -$15.41M derived: sum of 2 quarters · filed 2016-11-03 | -$26.46M 10-Q · filed 2016-11-03 | -$40.76M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | -$6.75M 10-Q · filed 2016-08-11 | -$17.81M 10-Q · filed 2016-08-11 | -$32.10M derived: sum of 3 quarters · filed 2016-08-11 | -$43.01M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-03-31 | -$11.05M 10-Q · filed 2016-05-04 | -$25.35M derived: sum of 2 quarters · filed 2016-05-04 | -$36.25M derived: sum of 3 quarters · filed 2016-11-03 | -$48.12M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-12-31 | -$14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | -$25.20M derived: sum of 2 quarters · filed 2016-11-03 | -$37.07M derived: sum of 3 quarters · filed 2016-11-03 | -$49.72M 10-K · filed 2016-03-16 | |
| 2015-09-30 | -$10.91M 10-Q · filed 2016-11-03 | -$22.77M derived: sum of 2 quarters · filed 2016-11-03 | -$35.42M 10-Q · filed 2016-11-03 | -$47.40M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | -$11.87M 10-Q · filed 2016-08-11 | -$24.52M 10-Q · filed 2016-08-11 | -$36.50M derived: sum of 3 quarters · filed 2016-08-11 | -$45.87M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | -$12.65M 10-Q · filed 2016-05-04 | -$24.63M derived: sum of 2 quarters · filed 2016-05-04 | -$34.00M derived: sum of 3 quarters · filed 2016-05-04 | -$43.35M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | -$11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | -$21.35M derived: sum of 2 quarters · filed 2016-03-16 | -$30.70M derived: sum of 3 quarters · filed 2016-03-16 | -$36.04M 10-K · filed 2016-03-16 | |
| 2014-09-30 | -$9.37M 10-Q · filed 2015-11-04 | -$18.72M derived: sum of 2 quarters · filed 2015-11-04 | -$24.06M 10-Q · filed 2015-11-04 | -$30.71M derived: sum of 4 quarters · filed 2015-11-04 | |
| 2014-06-30 | -$9.35M 10-Q · filed 2015-08-05 | -$14.69M 10-Q · filed 2015-08-05 | -$21.34M derived: sum of 3 quarters · filed 2015-08-05 | -$27.32M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | -$5.33M 10-Q · filed 2015-05-14 | -$11.99M derived: sum of 2 quarters · filed 2015-05-14 | -$17.96M derived: sum of 3 quarters · filed 2015-05-14 | -$21.86M derived: sum of 4 quarters · filed 2015-05-14 | -$95.21M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$12.63M derived: sum of 2 quarters · filed 2015-02-26 | -$16.52M derived: sum of 3 quarters · filed 2015-02-26 | -$19.95M 10-K · filed 2015-02-26 | |
| 2013-09-30 | -$5.98M 10-Q · filed 2014-11-05 | -$9.87M derived: sum of 2 quarters · filed 2014-11-05 | -$13.30M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | -$3.89M 10-Q · filed 2014-08-05 | -$7.32M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$3.43M 10-Q · filed 2014-05-08 |